{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:54:19Z","timestamp":1789016059769,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007928","name":"Ningbo Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["2019B10039"],"award-info":[{"award-number":["2019B10039"]}],"id":[{"id":"10.13039\/501100007928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.humimm.2025.111566","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:17:39Z","timestamp":1755649059000},"page":"111566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gpx1 induces M2 polarization of macrophages, contributing to doxorubicin resistance in triple-negative breast cancer"],"prefix":"10.1016","volume":"86","author":[{"given":"Limu","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6813-4214","authenticated-orcid":false,"given":"Zhijun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.humimm.2025.111566_b0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.humimm.2025.111566_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.836417","article-title":"Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence","volume":"9","author":"Almansour","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.humimm.2025.111566_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111566_b0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111566_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13058-024-01783-z","article-title":"HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: are they connected?","volume":"26","author":"Baez-Navarro","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.humimm.2025.111566_b0030","article-title":"Neoadjuvant chemotherapy for breast cancer: past, present, and future","volume":"14","author":"Asaoka","year":"2020","journal-title":"Breast Cancer (Auckl.)"},{"issue":"4","key":"10.1016\/j.humimm.2025.111566_b0035","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1245\/s10434-020-09480-9","article-title":"The landmark series: neoadjuvant chemotherapy for triple-negative and HER2-positive breast cancer","volume":"28","author":"Leon-Ferre","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.humimm.2025.111566_b0040","article-title":"Predicting neoadjuvant treatment response in triple-negative breast cancer using machine learning","volume":"14","author":"Bhattarai","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.humimm.2025.111566_b0045","article-title":"The current role of neoadjuvant chemotherapy in the management of HER2-positive, triple-negative, and micropapillary breast cancer: a narrative review","volume":"15","author":"Wankhade","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.humimm.2025.111566_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin-an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.humimm.2025.111566_b0055","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1158\/1078-0432.CCR-21-3100","article-title":"Molecular characterization and prospective evaluation of pathologic response and outcomes with neoadjuvant therapy in metaplastic triple-negative breast cancer","volume":"28","author":"Yam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.humimm.2025.111566_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212438","article-title":"Doxorubicin-resistant TNBC cells exhibit rapid growth with cancer stem cell-like properties and EMT phenotype, which can be transferred to parental cells through autocrine signaling","volume":"22","author":"Paramanantham","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.humimm.2025.111566_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","article-title":"Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/beta-catenin signaling","volume":"20","author":"Chen","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"39","key":"10.1016\/j.humimm.2025.111566_b0070","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.2174\/0929867328666210720143721","article-title":"The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis \u2013 current status","volume":"28","author":"Dallavalasa","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.humimm.2025.111566_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087493","article-title":"Tumor-associated macrophage subsets: shaping polarization and targeting","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2025.111566_b0080","article-title":"Shaping polarization of tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2025.111566_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102463","article-title":"Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing","volume":"56","author":"Hao","year":"2022","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.humimm.2025.111566_b0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41419-023-06383-x","article-title":"TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.humimm.2025.111566_b0095","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5440","article-title":"PD\u2011L1 mediates triple\u2011negative breast cancer evolution via the regulation of TAM\/M2 polarization","volume":"61","author":"Meng","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111566_b0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41401-020-0419-1","article-title":"Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer","volume":"42","author":"Deng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.humimm.2025.111566_b0105","article-title":"Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy","volume":"5","author":"Yang","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"8","key":"10.1016\/j.humimm.2025.111566_b0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/CJI.0000000000000519","article-title":"Vitexin inhibits TNBC progression and metastasis by modulating macrophage polarization through EGFR signaling","volume":"47","author":"Lin","year":"2024","journal-title":"J Immunother"},{"issue":"10","key":"10.1016\/j.humimm.2025.111566_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102560","article-title":"Glutathione peroxidase GPX1 and its dichotomous roles in cancer","volume":"14","author":"Zhao","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2025.111566_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111533","article-title":"Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression","volume":"142","author":"Gong","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"24","key":"10.1016\/j.humimm.2025.111566_b0125","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.18632\/aging.102555","article-title":"GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer","volume":"11","author":"Cheng","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.humimm.2025.111566_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2022.127082","article-title":"Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma","volume":"74","author":"Chen","year":"2022","journal-title":"J. Trace Elem. Med Biol."},{"issue":"12","key":"10.1016\/j.humimm.2025.111566_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12214","article-title":"Bioinformatics analysis on the expression of GPX family in gastric cancer and its correlation with the prognosis of gastric cancer","volume":"8","author":"Ye","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.humimm.2025.111566_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101391","article-title":"Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling","volume":"29","author":"Lee","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.humimm.2025.111566_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102993","article-title":"M(6)A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer","volume":"69","author":"Liu","year":"2024","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.humimm.2025.111566_b0150","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1080\/15548627.2023.2182482","article-title":"Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1","volume":"19","author":"Liu","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.humimm.2025.111566_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105975","article-title":"Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein","volume":"175","author":"Abd-Ellatef","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.humimm.2025.111566_b0160","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.7150\/ijbs.65555","article-title":"High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level","volume":"18","author":"Luo","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.humimm.2025.111566_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.780839","article-title":"Modulation of macrophage immunometabolism: a new approach to fight infections","volume":"13","author":"Gauthier","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111566_b0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.humimm.2025.111566_b0175","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.humimm.2025.111566_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910781","article-title":"Key players in the battle against triple-negative breast cancer","volume":"25","author":"Padzinska-Pruszynska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.humimm.2025.111566_b0185","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41388-024-03030-3","article-title":"COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.humimm.2025.111566_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2021.104296","article-title":"MiR-185-5p suppresses acute myeloid leukemia by inhibiting GPX1","volume":"140","author":"Pang","year":"2022","journal-title":"Microvasc. Res."},{"issue":"1","key":"10.1016\/j.humimm.2025.111566_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166268","article-title":"GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression","volume":"1868","author":"Zhang","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"6","key":"10.1016\/j.humimm.2025.111566_b0200","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.21037\/tau-20-1398","article-title":"Comprehensive analysis of glutathione peroxidase-1 (GPX1) expression and prognostic value in three different types of renal cell carcinoma","volume":"9","author":"Chen","year":"2020","journal-title":"Transl. Androl. Urol."},{"issue":"10","key":"10.1016\/j.humimm.2025.111566_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/nu12102999","article-title":"Macrophage polarization and osteoporosis: a review","volume":"12","author":"Munoz","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.humimm.2025.111566_b0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1631\/jzus.B2400192","article-title":"CXCL16 promotes proliferation of head and neck squamous cell carcinoma by regulating GPX1-mediated antioxidant levels","volume":"26","author":"He","year":"2024","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.humimm.2025.111566_b0215","first-page":"11","article-title":"\u201cRe-educating\u201d tumor associated macrophages as a novel immunotherapy strategy for neuroblastoma","volume":"2020","author":"Liu","year":"1947","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2025.111566_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104119","article-title":"The roles of tumor-associated macrophages in tumor angiogenesis and metastasis","volume":"353","author":"Fu","year":"2020","journal-title":"Cell. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:01:40Z","timestamp":1762264900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925003374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0198885925003374"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111566","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gpx1 induces M2 polarization of macrophages, contributing to doxorubicin resistance in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"111566"}}